TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8167164

Group type: EXPERIMENTAL
Intervention: Group relaxation training and thermal biofeedback
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 101
Study: 3283093

Group type: EXPERIMENTAL
Intervention: Amoxycillin sachets 3g twice daily for three days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Amoxycillin capsules 500 mg three times daily for seven days
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Short course high dose therapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional course amoxycillin
Number of subjects: 41
Study: 31296601

Group type: EXPERIMENTAL
Intervention: SMC+LP
Number of subjects: 100

Group type: COMPARATOR
Intervention: SMC
Number of subjects: 100
Study: 29696564

Group type: EXPERIMENTAL
Intervention: M2000 (β-D-mannuronic acid) administered at a dose of two capsules (500 mg) per day orally for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: M2000 (β-D-mannuronic acid)
Number of subjects: 0
Study: 27177524

Group type: EXPERIMENTAL
Intervention: Obese women after protocol implementation
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Obese women before protocol implementation
Number of subjects: 5000
Study: 24337884

Group type: EXPERIMENTAL
Intervention: Early diet group (clear liquid diet on day 0, soft diet and general diet on day 1)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Early diet group
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (fasted for 2 days)
Number of subjects: 130
Study: 23200102

Group type: EXPERIMENTAL
Intervention: GNbAC1 0.0025, 0.025, 0.15, 0.6, 2, or 6 mg/kg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (inactive vehicle)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: GNbAC1 2 and 6 mg/kg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: GNbAC1
Number of subjects: 33
Study: 19130358

Group type: EXPERIMENTAL
Intervention: Living in the household of origin continuously (IN)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Leaving and never returning (OUT)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Multiple moves in and out of the household (IN/OUT)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Older adolescent maternal age, less supportive adolescent mother-grandmother relations, and high household density
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: IN/OUT group
Number of subjects: 181
Study: 17957907

Group type: EXPERIMENTAL
Intervention: Ginger (0.5 gm capsule, twice daily)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Dimenhydrinate (50 mg capsule, twice daily)
Number of subjects: 170
Study: 15119721

Group type: EXPERIMENTAL
Intervention: AH 26 with lateral condensation
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: AH Plus with lateral condensation
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: AH 26 with hybrid condensation
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: AH Plus with hybrid condensation
Number of subjects: 940

Group type: COMPARATOR
Intervention: Thermafil
Number of subjects: 940

Group type: COMPARATOR
Intervention: Hybrid condensation
Number of subjects: 940

Group type: COMPARATOR
Intervention: Lateral condensation
Number of subjects: 940
Study: 11468200

Group type: EXPERIMENTAL
Intervention: Eptifibatide (180 microgram/kg bolus and 2.0 microgram/kg per minute infusion for 72 hours)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 9491878

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 8312416

Group type: EXPERIMENTAL
Intervention: 6000 U subcutaneously once a week
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 9000 U subcutaneously once a week
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 12000 U subcutaneously once a week
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 6000 U subcutaneously once every 2 weeks
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 9000 U subcutaneously once every 2 weeks
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 12000 U subcutaneously once every 2 weeks
Number of subjects: 41
Study: 3338011

Group type: EXPERIMENTAL
Intervention: CAF (cyclophosphamide, Adriamycin, and 5-fluorouracil) with or without tamoxifen
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: CAF (cyclophosphamide, Adriamycin, and 5-fluorouracil) with tamoxifen
Number of subjects: 46

Group type: COMPARATOR
Intervention: CAF (cyclophosphamide, Adriamycin, and 5-fluorouracil)
Number of subjects: 46
Study: 29395560

Group type: EXPERIMENTAL
Intervention: Surgical mask during 6MWT
Number of subjects: 44

Group type: COMPARATOR
Intervention: No surgical mask during 6MWT
Number of subjects: 44
Study: 26849256

Group type: EXPERIMENTAL
Intervention: Welding fumes containing zinc
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Welding fumes containing copper
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Welding fumes containing both copper and zinc
Number of subjects: 15
Study: 25600160

Group type: EXPERIMENTAL
Intervention: Clinical variables (model 1)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: HRQoL-scores (model 2)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 623
Study: 24429127

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 50 μg + vilanterol 25 μg
Number of subjects: 3255

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 100 μg + vilanterol 25 μg
Number of subjects: 3255

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 200 μg + vilanterol 25 μg
Number of subjects: 3255

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 50 μg + vilanterol 25 μg (pooled analysis)
Number of subjects: 3255

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 100 μg + vilanterol 25 μg (pooled analysis)
Number of subjects: 3255

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 200 μg + vilanterol 25 μg (pooled analysis)
Number of subjects: 3255

Group type: COMPARATOR
Intervention: Vilanterol only
Number of subjects: 3255
Study: 21903957

Group type: EXPERIMENTAL
Intervention: Isoflavone soy protein (ISP) supplementation (25 g daily for 2.7 years)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Isoflavone soy protein (ISP) supplementation (25 g daily for 2.7 years) in women <5 years postmenopausal
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo in women <5 years postmenopausal
Number of subjects: 350
Study: 19086328

Group type: EXPERIMENTAL
Intervention: Panitumumab monotherapy
Number of subjects: 463

Group type: COMPARATOR
Intervention: Best supportive care (control group)
Number of subjects: 463
Study: 17030766

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 12806269

Group type: EXPERIMENTAL
Intervention: Training of eating behavior and satiety, supply of warmth, reduction of physical hyperactivity, and restoration of social activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressants (SSRIs)
Number of subjects: 0
Study: 10450292

Group type: EXPERIMENTAL
Intervention: Combination diet (rich in fruits, vegetables, and low-fat dairy products)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Fruits and vegetables diet
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Combination diet (in participants with hypertension)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Combination diet (in participants without hypertension)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Minority subgroup analysis
Number of subjects: 459
Study: 8738446

Group type: EXPERIMENTAL
Intervention: Forceful epidural corticosteroid injections (125 mg prednisolone acetate + 40 ml saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (125 mg prednisolone acetate alone)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Forceful epidural corticosteroid injections
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 2018658

Group type: EXPERIMENTAL
Intervention: STH + CP (creatine phosphate 10.0 mmol/l)
Number of subjects: 50

Group type: COMPARATOR
Intervention: STH (control group)
Number of subjects: 50
Study: 6129674

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31607387

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (loading dose of 500 mg and continuous infusion of 250 mg h‐1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 100
Study: 29850764

Group type: EXPERIMENTAL
Intervention: Pictorial warning
Number of subjects: 2149

Group type: COMPARATOR
Intervention: Text-only warning
Number of subjects: 2149
Study: 28277823

Group type: EXPERIMENTAL
Intervention: Virgin Coconut Oil (VCO)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Safflower Oil (SO)
Number of subjects: 12
Study: 25365652

Group type: EXPERIMENTAL
Intervention: Block Allograft (BA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sandwich Bone Augmentation (SBA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 24707200

Group type: EXPERIMENTAL
Intervention: Deep tissue massage (DTM)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Combined therapy of DTM and NSAID
Number of subjects: 59
Study: 22960162

Group type: EXPERIMENTAL
Intervention: Motivational coaching at home and by phone with a health educator, mailed educational materials, and weekly text messages for 6 months.
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control condition (details not specified).
Number of subjects: 121
Study: 20071900

Group type: EXPERIMENTAL
Intervention: Koryo Hand Therapy (KHT), applied three times a week for 8 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 45
Study: 17395516

Group type: EXPERIMENTAL
Intervention: Weekly medical support through SMS based upon weekly review of glucose values
Number of subjects: 30

Group type: COMPARATOR
Intervention: No SMS (self‐monitored blood glucose values downloaded weekly without SMS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SMS sequence
Number of subjects: 30

Group type: COMPARATOR
Intervention: No SMS period
Number of subjects: 30
Study: 15530684

Group type: EXPERIMENTAL
Intervention: dTpa vaccine
Number of subjects: 550

Group type: COMPARATOR
Intervention: Td vaccine
Number of subjects: 550
Study: 11642579

Group type: EXPERIMENTAL
Intervention: Sensitisation to dust mite
Number of subjects: 3985

Group type: EXPERIMENTAL
Intervention: Sensitisation to cat
Number of subjects: 3985

Group type: EXPERIMENTAL
Intervention: Sensitisation to grass pollen
Number of subjects: 3985

Group type: EXPERIMENTAL
Intervention: Sensitisation to birch pollen (in Austria)
Number of subjects: 3985

Group type: EXPERIMENTAL
Intervention: Sensitisation to parietaria (in Greece)
Number of subjects: 3985

Group type: COMPARATOR
Intervention: Comparative analysis of asthma and hay fever risk
Number of subjects: 3985

Group type: EXPERIMENTAL
Intervention: Risk of dust mite allergy
Number of subjects: 3985

Group type: EXPERIMENTAL
Intervention: Risk of cat and grass pollen allergy
Number of subjects: 3985
Study: 10102965

Group type: EXPERIMENTAL
Intervention: 7-day therapy with ranitidine bismuth citrate 400 mg b.d., metronidazole 500 mg b.d. and tetracycline 500 mg b.d.
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 10-day therapy with ranitidine bismuth citrate 400 mg b.d., metronidazole 500 mg b.d. and tetracycline 500 mg b.d.
Number of subjects: 105
Study: 7778649

Group type: EXPERIMENTAL
Intervention: Pipelle endocervical aspiration (n = 24)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Kevorkian curette (n = 28)
Number of subjects: 52
Study: 2185825

Group type: EXPERIMENTAL
Intervention: Maize starch paste with 240 g amylose/kg (S24)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Maize starch paste with 500 g amylose/kg (S50)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Glucose solution (GS)
Number of subjects: 9
Study: 6109469

Group type: EXPERIMENTAL
Intervention: Midazolam (0.15 mg/kg body weight) injected over 60 seconds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam (0.15 mg/kg body weight) injected over 15 seconds
Number of subjects: 0
Study: 29029135

Group type: EXPERIMENTAL
Intervention: Simeprevir 150mg once daily for 7 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50mg once daily for 7 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Simeprevir 150mg once daily plus Dolutegravir 50mg once daily for 7 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 27459502

Group type: EXPERIMENTAL
Intervention: Group-based lifestyle modification program (1 individual session, 5 group sessions, 2 telephone sessions)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Group-based lifestyle modification program
Number of subjects: 573

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 573
Study: 24732833

Group type: EXPERIMENTAL
Intervention: Navigated technique (3D fluoroscopy-based)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-navigated technique (2D fluoroscopy-guided)
Number of subjects: 21
Study: 22708417

Group type: EXPERIMENTAL
Intervention: Physical training (PT) combined with standard pharmacotherapy and respiratory training
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard pharmacotherapy
Number of subjects: 112
Study: 20484089

Group type: COMPARATOR
Intervention: DA (Decision Aid)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: DA + VC (Decision Aid + Values Clarification)
Number of subjects: 137
Study: 18842422

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning
Number of subjects: 21

Group type: COMPARATOR
Intervention: Unstable angina
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (stable patients)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (unstable patients)
Number of subjects: 21
Study: 15974417

Group type: EXPERIMENTAL
Intervention: Topical morphine (10 mg morphine hydrochloride with Intrasite Gel)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (Intrasite Gel with placebo)
Number of subjects: 24
Study: 12902209

Group type: EXPERIMENTAL
Intervention: Three drugs FDC
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Four drugs FDC
Number of subjects: 42

Group type: COMPARATOR
Intervention: WHO simplified protocol
Number of subjects: 42
Study: 10826029

Group type: EXPERIMENTAL
Intervention: Family-focused psychosocial intervention for stroke survivors
Number of subjects: 0
Study: 8863695

Group type: EXPERIMENTAL
Intervention: Inactive urinary kallikrein: creatinine ratio (IUK:Cr)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Angiotensin sensitivity test (AST)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Low-dose aspirin (60 mg)
Number of subjects: 459
Study: 1296495

Group type: EXPERIMENTAL
Intervention: Ioversol 350
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iohexol 350
Number of subjects: 0
Study: 6094443

Group type: EXPERIMENTAL
Intervention: Cefotaxime (1 g im or iv on call to the operating room)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Cefoxitin (2 g im or iv on call to the operating room, followed by 2 g intravenously at 6 hourly intervals for up to 24 h)
Number of subjects: 178
Study: 2948731

Group type: EXPERIMENTAL
Intervention: 5 g/m2 5'‐dFUrd
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3 g/m2 5'‐dFUrd
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5'‐dFUrd
Number of subjects: 18
Study: 29733038

Group type: EXPERIMENTAL
Intervention: Monitoring of depression using the MADRS-S depression scale during GP visits at baseline and at visits 4, 8, and 12 weeks.
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Monitoring of depression using the MADRS-S depression scale during GP visits.
Number of subjects: 183

Group type: COMPARATOR
Intervention: Regular treatment (control group).
Number of subjects: 183
Study: 27718781

Group type: EXPERIMENTAL
Intervention: Sunitinib (50 mg per day, 4-weeks-on, 2-weeks-off for 1 year)
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 615
Study: 24511614

Group type: EXPERIMENTAL
Intervention: Energy labelling
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Single traffic light labelling
Number of subjects: 329

Group type: COMPARATOR
Intervention: No-label control
Number of subjects: 329
Study: 22236951

Group type: EXPERIMENTAL
Intervention: Salsa dancing (8-week progressive programme)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 19720471

Group type: EXPERIMENTAL
Intervention: Brief risk reduction counseling (BRRC)
Number of subjects: 4298

Group type: COMPARATOR
Intervention: Informational condition
Number of subjects: 4298
Study: 18551108

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Daily exercise (EX)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Baseline weight gain on weekends
Number of subjects: 48
Study: 15742089

Group type: EXPERIMENTAL
Intervention: Methacholine challenge
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Free running exercise challenge
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cycle ergometer exercise challenge
Number of subjects: 30
Study: 14556925

Group type: EXPERIMENTAL
Intervention: Glufosfamide (5 g/m²) administered via 1-hour intravenous infusion every 3 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Active-hydration
Number of subjects: 35
Study: 10759342

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus Pindolol (FLX + PIN)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Fluoxetine plus Placebo (FLX + PLA)
Number of subjects: 111
Study: 8636433

Group type: EXPERIMENTAL
Intervention: IL-2 therapy
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no IL-2 therapy)
Number of subjects: 6
Study: 1467895

Group type: EXPERIMENTAL
Intervention: Skin staples
Number of subjects: 48

Group type: COMPARATOR
Intervention: Subcuticular polydioxanone sutures
Number of subjects: 48
Study: 6731261

Group type: EXPERIMENTAL
Intervention: Trimazosin (2 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol (0.2 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (before treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise after Trimazosin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise after Propranolol
Number of subjects: 10
Study: 31830830

Group type: COMPARATOR
Intervention: Blood Flow Restricted Resistance Exercise (BFRRE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning (RIC)
Number of subjects: 36
Study: 29794048

Group type: EXPERIMENTAL
Intervention: Social condition (public evaluations)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Asocial condition (private evaluations)
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Social condition first followed by asocial condition
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Conformity and self-consistency mechanisms
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Gender differences in conformity
Number of subjects: 878
Study: 26609008

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (AA) 1 g plus prednisone 5 mg twice daily
Number of subjects: 2044

Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 2044
Study: 25443601

Group type: EXPERIMENTAL
Intervention: Yoga based cardiac rehabilitation program
Number of subjects: 250

Group type: COMPARATOR
Intervention: Physiotherapy based program
Number of subjects: 250
Study: 22158680

Group type: EXPERIMENTAL
Intervention: mOPV1 (2 manufacturers)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: mOPV3 (1 manufacturer)
Number of subjects: 800

Group type: COMPARATOR
Intervention: tOPV
Number of subjects: 800
Study: 21702260

Group type: EXPERIMENTAL
Intervention: Open cholecystectomy without drainage
Number of subjects: 212

Group type: COMPARATOR
Intervention: Open cholecystectomy with intra-peritoneal drain
Number of subjects: 212
Study: 17685870

Group type: EXPERIMENTAL
Intervention: Local therapies (anti-vascular endothelial growth factor strategies, anti-inflammatory agents, gene therapy, and stem cell therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic drug administration (protein kinase C inhibitors and somatostatin analogs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravitreal delivery of local therapies
Number of subjects: 0
Study: 15573392

Group type: EXPERIMENTAL
Intervention: Spirotel portable spirometer
Number of subjects: 59

Group type: COMPARATOR
Intervention: Laboratory spirometer (Jeager PFT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both spirometers
Number of subjects: 59
Study: 12066727

Group type: COMPARATOR
Intervention: 0.5% lidocaine solution 3 mg kg(‐1) (n=20)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: mepivacaine 5 mg kg(‐1) (n=22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: lidocaine 3 mg kg(‐1) (n=20)
Number of subjects: 42
Study: 10718563

Group type: EXPERIMENTAL
Intervention: Intense interval training (10 x 400 m at 5.94+/‐0.19 m x s(‐1) with recovery of 60, 120 or 180 s)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intense interval training
Number of subjects: 7
Study: 8872694

Group type: EXPERIMENTAL
Intervention: Intravenous glycopyrrolate
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intramuscular glycopyrrolate
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Oral glycopyrrolate
Number of subjects: 37
Study: 1640303

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (no antibiotic treatment)
Number of subjects: 47
Study: 6430690

Group type: EXPERIMENTAL
Intervention: Phenobarbital (PB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phenytoin (DPH)
Number of subjects: 40
Study: 31414980

Group type: EXPERIMENTAL
Intervention: Diet therapy with <5 g long chain triglyceride fat per day recommended by dietitians in Australia/New Zealand, UK, and Ireland
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Diet therapy duration of 4 weeks or 6 weeks
Number of subjects: 64